Pharmacology Books
Edinburgh University Press Arabian Drugs in Early Medieval Mediterranean
Book SynopsisThis book explores the impact of Greek (as well as Indian and Persian) medical heritage on the evolution of Arab medicine and pharmacology, investigating it from the perspective of 'materia medica' a reliable indication of the contribution of this medical legacy.
£33.30
Pharmaceutical Press Nonprescription Medicines
Book SynopsisThis new edition of Non-prescription Medicines reviews over-the-counter (OTC) medicines currently available in the UK, in alphabetically arranged chapters on the conditions that they are licensed to treat.
£36.00
Elsevier - Health Sciences Division Workbook for Raus Respiratory Care Pharmacology
Book SynopsisTable of ContentsUnit I: Basic Concepts and Principles in Pharmacology 1. Introduction to Respiratory Care Pharmacology 2. Principles of Drug Action 3. Administration of Aerosolized Agents 4. Calculating Drug Doses 5. The Central and Peripheral Nervous Systems Unit II: Drugs Used to Treat the Respiratory System 6. Adrenergic (Sympathomimetic) Bronchodilators 7. Anticholinergic (Parasympatholytic) Bronchodilators 8. Xanthines 9. Mucus-Controlling Drug Therapy 10. Surfactant Agents 11. Corticosteroids in Respiratory Care 12. Nonsteroidal Antiasthma Agents 13. Aerosolized Antiinfective Agents 14. Antimicrobial Agents 15. Cold and Cough Agents 16. Selected Agents of Pulmonary Value 17. Neonatal and Pediatric Aerosolized Drug Therapy Unit III: Critical Care, Cardiovascular, and Polysomnography Agents 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents) 19. Diuretic Agents 20. Drugs Affecting the Central Nervous System 21. Vasopressors, Inotropes, and Antiarrhythmic Agents 22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics 23 Sleep and Sleep Pharmacology
£35.14
F.A. Davis Company Pharm Phlash!: Pharmacology Flash Cards
Book SynopsisThe best flashcards to test yourself on the top drugs & prepare for the NCLEX®! Increase your test scores in pharmacology class. Build your confidence to pass the NCLEX®. Expand your understanding of pharmacological agents. Decrease and prevent medication errors in practice. These flashcards put critical clinical information for nearly 400 of the top generic medications at your fingertips. Each card features a single generic drug or a medication group to help build associations between common medications and includes indications for use of the drug, action of the drug, route/dosage information, adverse reactions/side effects, pre-administration vital signs, laboratory data assessment, drug levels, patient teaching, and more. Count on them for accuracy because each card is based on content from Davis’s Drug Guide for Nurses®. AMAZING and MUST GET!“These cards are a MUST for any nursing student or even nurse! I use these for almost every single assignment from nursing process sheets to care plans. You need to get these immediately, and you’ll love them!! Seriously, I am so glad I stumbled upon these cards. Thank you to whoever invented these!”—Edgar G. GREAT for Nursing Students“I used these cards to pass my pharmacology final and my NCLEX in nursing school! I love these cards. They have all the info you need on the card, and even helpful tips.”—Cloie Updated & Revised! Completely reviewed and updated to ensure accuracy A color-coded, body-system organization reflects the information common to classes of medications. Each card features a single generic drug or a medication group to help build associations between common medications and includes indications for use of the drug, action of the drug, adverse reactions/side effects, pre-administration vital signs, laboratory data assessment, drug levels, patient teaching, and more. “Make the Connection” highlights information crucial to administering medications safely, understanding the clinical applicability of the information, and helps to develop critical-thinking skills. “Keep in Mind” provides key nursing considerations, including client teaching. Route/dosage information appears on the back of each card. Common abbreviations listed on each card, with a summary of the abbreviations on separate, introductory cards. A comprehensive, alphabetical Index makes it easy to locate drugs within the deck by trade, generic, or Canadian brand name. New! Card listing commonly used monoclonal antibodies, their brand and generic names, and indications for use New! Cards explaining the cytochrome P450 (CYP 450) enzyme system, how the enzymes effect the levels of other drugs with a list of strong and moderate inhibitors and inducers New! CYP3A4 inducer or inhibiter descriptions in the “Make the Connection” section on each card, when appropriate New! Cards for VMAT2 inhibiters in the central nervous system section Table of ContentsKey to Abbreviations Key to Icons Introduction Drug Cards covering... • Gastrointestinal System Drugs • Endocrine System Drugs • Urologic System Drugs • Immune System Drugs • Musculoskeletal System Drugs • Central Nervous System Drugs • Cardiovascular System Drugs • Respiratory System Drugs • Sensory System Drugs Index
£33.26
Hachette Go Psychedelics
Book Synopsis
£15.99
Jessica Kingsley Publishers Fragrance and Wellbeing: Plant Aromatics and
Book SynopsisFor thousands of years fragrance has been used, across many varied cultures, for altering mental and emotional states, and as part of spiritual practice. This book explores the impact of fragrance on the psyche from biological, anthropological, perfumery and aromatherapy viewpoints. Beginning with an exploration of our olfactory system and a discussion of the language of odour, the author examines the ways in which fragrance can influence our perceptions and experiences. She introduces us to a broad range of fragrance types - woody, resinous, spicy, herbaceous, agrestic, floral and citrus, as well as the attars that form part of Unani Tibb medicine. Traditional and contemporary uses and the mood-enhancing properties of fragrance types are presented. The book then provides an overview of the theoretical and philosophical frameworks that have been used to analyse how and why we choose fragrance. Finally readers are given guidance on how to cultivate their olfactory palate, which reveals a new dimension in the use of fragrance to enhance wellbeing.This book offers a wealth of knowledge on plant aromatics and the powerful influence of fragrance on wellbeing. It will be of particular interest to aromatherapists, perfumers, psychotherapists, ethnobotanists and anthropologists.Trade ReviewThis book explores the impact of fragrance on the psyche from biological, anthropological, perfumery and aromatherapy viewpoints... Readers are given guidance on how to cultivate their olfactory plate, which reveals a new dimension in the use of fragrance to enhance wellbeing. This book offers a wealth of knowledge on plant aromatics and the powerful influence of fragrance on wellbeing. It will be of particular interest to aromatherapists, perfumers, psychotherapists, ethnobotanists and anthropologists. -- Embody MagazineThis book takes in a fantastic range of topics, including the biology of fragrance, the social life of scents, the healing powers of smell and incense rituals from around the world. Its central chapters profile the uses of an impressive list of aromatics (blending myth, folklore and science) and it concludes with some vital suggestions for cultivating our olfactory palate. Written by a true perfume lover, Fragrance and Wellbeing makes for heady reading. -- David Howes, Professor of Anthropology, Concordia University, Montreal and co-author of Aroma: The Cultural History of Smell (1994) and Ways of Sensing: Understanding the Senses in Society (2013)Jennifer Peace Rhind transports the reader on a fascinating journey while exploring the influence of scent on the development of civilization. This well-referenced book includes research within the last century regarding the use of fragrance throughout history. Fragrance and Wellbeing investigates our evolving relationship with the language of scent and its impact on the personal, cultural, spiritual and therapeutic domains with an acknowledgement to new observations for the possible effects of fragrance. A thoroughly interesting, informative and engaging read! -- Lora Cantele, Editor, International Journal of Professional Holistic AromatherapyA walk through an oriental bazaar, contemplation in a Hindu temple, and reading Rhind's Fragrance and Wellbeing are three experiences that provide a clear insight into what Westerners miss by pushing our sense of smell aside. By presenting ample cross-cultural, historical and psychological evidence, Rhind persuasively argues why we should take our nose seriously. -- Dr Jan Havlícek, Department of Anthropology, Charles University, Prague, Czech RepublicJennifer Peace Rhind's classic delivers an in depth explanation of the effect natural plant perfumes have on the human psyche. This work not only covers a scientific summary of plant chemistry, but also the historical use of plants in shamanic and mystical traditions throughout the world...In this great work, the author explores the various odour types and characteristics encountered in plant fragrances in great detail, and goes on to list and describe plant categories... Having read (or at least scanned) many books on the subject of "Aromatherapy", I have found Jennifer Peace Rhind's "Fragrance and Wellbeing" - to be the one which will remain on my bookshelf, to be referred to and delved into often. A great work which deserves much revisiting. -- The HerbalistJennifer Peace Rhind is a trained chartered biologist who then undertook further studies in complementary therapies, including aromatherapy... She explores the sense of smell and how it works with the psyche... the emotional response to odors.... The evolution of perfume is explored..introduces us to the language of fragrance... I found this book fascinating and full of really great information. -- Jo Ketterman MARH * Homeopathy in practice *[This book] addresses how fragrance strongly links to our soul and spirit, and how each aroma plays a different part in addressing the problems of the mind (...) [with] comprehensive descriptions of the wide variety of natural aromas to be found in the plant world (...) in my decade-plus long experience in the world of aromatherapy, I learned many new things from this book. -- Sharon Falsetto * NAHA Aromatherapy Journal, Winter 2017.4 *Table of ContentsPreface. Introduction. Part I. Scent: A Pan-Dimensional Perspective. 1. The Fallen Angel. 2. Smell and the psyche. 3. Per fumum. 4. Perfume: The transcendence of the sweet life. Part II. A Natural Palette of Aromatics. 5. Fragrance philosophies. 6. Woody, resinous, balsamic and coniferous scents. 7. Spices. 8. Herbaceous, green, camphoraceous, cineolic and agrestic scented botanicals. 9. Flowers. 10. Citrus, lemon-scented botanicals and fruity fragrances. 11. Attars and the role of fragrance in Unani Tibb medicine (Jeannie Fatimeh Graham). In conclusion. 12. Cultivating the olfactory palate. Glossary. Appendix A. Classification of fragrance. Appendix B. Ambergris. Appendix C. Fragrance and the four elements. Appendix D. Developing sensory appreciation of plant aromatics, essential oils, absolutes and fragrances. References. Bibliography for Chapter 11. Recommended reading.
£29.45
American Pharmacists Association The Art, Science, and Technology of
Book SynopsisThe Art, Science, and Technology of Pharmaceutical Compounding, 6th Edition has been completely revised and covers all aspects of pharmaceutical compounding. Featured are the regulations,technology, scientific foundation, and clinical consulting aspects of the dosage forms that can be compounded. It also contains example formulas for all dosage forms along with the ingredients, quantities, use of each ingredient, and instructions for preparation. In addition to formulation development including flavoring, sweetening, preservation and compliance and compatibility considerations, quality control and areas of potential errors are also presented.More than ever, there is a need for a practical compounding reference that integrates the science and practice of compounding while emphasizing the need for caution, innovation, and patient counseling.KEY FEATURES: Covers all aspects of nonsterile and sterile as well as nonhazardous and hazardous compounding. Blends the scientific and technologic aspects of compounding to support an understanding of the importance of each compounded dosage form. Presents different technologies for compounding various dosage forms, as well as example. Formulations for all dosage forms presented in the book. Features an entirely new chapter emphasizing the pharmacist’s role in addressing incompatibilities and their potential clinical effects.
£127.80
Cambridge University Press Pharmacology for Anaesthesia and Intensive Care
Book SynopsisThe fifth edition of this popular textbook continues to provide a solid foundation of pharmacological knowledge for all those working in anaesthesia and intensive care. The content has been thoroughly revised to include expanded chapters with clearer figures, ensuring readers are kept abreast of the ever-changing landscape of clinical pharmacology. Conveniently divided into four sections covering the basic principles of pharmacology, core drugs in anaesthetic practice, cardiovascular drugs, and other important drugs and complemented by new diagrams, tables and chemical formulae to facilitate learning. All four chapters on core drugs in anaesthetic practice have been updated along with others exploring applied pharmacokinetic models, antimicrobials, and drugs used in diabetes. An ideal aid to study and practice for junior and trainee anaesthetists and intensive care specialists preparing for exams. Also an invaluable resource for theatre practitioners, ICU nurses and physicians working in areas that demand a solid knowledge of pharmacology.Trade Review'This outstanding book differentiates itself from others through its effective use of figures and diagrams that enhance learning. It is comprehensive and provides sufficient detail for the use of these medications. The information is not so overwhelming as to render it forgotten after reading. The inclusion of new anticoagulants and their reversal and the update on antibiotics make this new edition necessary.' Robert R. Gaiser, Doody's Notes'… an invaluable resource for anyone, both doctor or nurse/ODP working in anaesthesia and intensive care. Its well-written explanations on the topics offer easy to understand insight which will only benefit the reader and lead to a greater depth of knowledge.' Daniel Morgan, The Journal of Perioperative Practice'A pleasant surprise for the reader will be how easily these subsections flow as the authors keep the more detailed and in-depth information accessible and interesting by associating the concepts to relevant drugs … This book is useful for trainees preparing for examinations and for experienced practitioners as a shelf reference; it is well organised so that specific topics or drugs can be individually reviewed.' Daniel Pulsipher, British Journal of AnaesthesiaTable of ContentsPreface: Foreword by Anthony Absalom; Section I. Basic Principles: 1. Drug passage across the cell membrane; 2. Absorption, distribution, metabolism and excretion; 3. Drug action; 4. Drug interaction; 5. Isomerism; 6. Pharmacokinetic modelling; 7. Applied pharmacokinetic models; 8. medicinal chemistry; Section II. Core Drugs in Anaesthetic Practice: 9. General anaesthetic agents; 10. Analgesics; 11. Local anaesthetics; 12. Muscle relaxants and reversal agents; Section III. Cardiovascular Drugs: 13. Sympathomimetics; 14. Adrenoceptor antagonists; 15. Anti-arrhythmics; 16. Vasodilators; 17. Antihypertensives; Section IV. Other Important Drugs: 18. Central nervous system; 19. Antiemetics and related drugs; 20. Drugs acting on the gut; 21. Intravenous fluids, minerals and nutrition; 22. Diuretics; 23. Antimicrobials; 24. Drugs affecting coagulation; 25. Drugs used in diabetes; 26. Corticosteroids and other hormone preparations; Index.
£55.99
Elsevier Health Sciences Drug Discovery and Development
Book SynopsisTable of ContentsSection 1 Introduction and Background 1. Development of the pharmaceutical industry 2. Nature of disease and purpose of therapy 3. Therapeutic modalities Section 2 Drug Discovery 4. Drug target identification 5. Selecting the modality and planning the project 6. High throughput screening 7. Medicinal Chemistry 8. Biopharmaceuticals and related molecules 9. Emerging modalities: nucleotide based therapy, cell based therapy, gene therapy / Novel and Advanced Process 10. Metabolism and Pharmacokinetical strategies. 11. Role of pharmacology to include pharmacology of newer modalities 12. In vitro in vivo translation 13. Vaccines Section 3 Drug Development 14. Drug development introduction 15. Drug safety 16. Pharmaceutical development 17. Clinical development 18. Clinical imaging 19. Intellectual property 20. Regulatory affairs 21. Marketing and Patient access to medicines Section 4 Facts and Figures 22. Facts and Figures; and the Future
£47.49
John Wiley & Sons Inc Vaccine Development and Manufacturing
Book SynopsisVaccine Production and Manufacturing is a valuable reference on how to produce a vaccine, from beginning to end. It addresses all classes of vaccines from a processing, production, and regulatory viewpoint. It covers everything from fermentation, purification, and formulation to regulatory filing and facility design.Table of ContentsAcknowledgments vii Preface ix Contributors xi 1 History of Vaccine Process Development 1Narahari S. Pujar, Sangeetha L. Sagar, and Ann L. Lee 2 The Production of Plasmid DNA Vaccine in Escherichia coli: A Novel Bacterial-Based Vaccine Production Platform 25Michel Chartrain 3 Fungal Expression Systems for Vaccine Production 51Karl Melber, Volker Jenzelewski, Roland Weyhenmeyer, and Zbigniew Janowicz 4 Novel Expression Systems for Vaccine Production 81Shailaja Rabindran and Vidadi Yusibov 5 Viral Vaccines Purification 97Bernd Kalbfuss-Zimmermann and Udo Reichl 6 Protein Subunit Vaccine Purification 181Yan-ping Yang and Tony D’Amore 7 Conjugate Vaccine Production Technology 217Sudha Chennasamudram and Willie F. Vann 8 Stabilization and Formulation of Vaccines 237Timothy S. Priddy and C. Russell Middaugh 9 Lyophilization in Vaccine Processes 263Alexis Wasserman, Ranjit Sarpal, and Bret R. Phillips 10 Strategies for Heat-Stable Vaccines 287Satoshi Ohtake, David Lechuga-Ballesteros, Vu Truong-Le, and Eric J. Patzer 11 Production and Characterization of Aluminum-Containing Adjuvants 319Stanley L. Hem and Cliff T. Johnston 12 The Biologics License Application (BLA) in Common Technical Document (CTD) Format 347R.S. Robin Robinett 13 The Original New Drug Application (Investigational New Drug) 373R.S. Robin Robinett 14 Facility Design for Vaccine Manufacturing—Regulatory, Business, and Technical Considerations and A Risk-Based Design Approach 393Anand Ekambaram and Abraham Shamir 15 Vaccine Production Economics 413Andrew Sinclair and Peter Latham Index 437
£116.06
Chelsea Green Publishing Co The LDN Book, Volume Two: The Latest Research on
Book SynopsisA comprehensive examination of Low Dose Naltrexone – a little-known drug with big potential New drug [LDN] raises hopes of reversing memory loss in old age the Guardian A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. Expanding on the information presented in The LDN Book, Volume 1 – which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue – Volume 2 highlights the latest clinical trials, case studies and research on LDN. More than a dozen medical professionals explain how they are using LDN to help patients suffering from: Chronic pain Parkinson’s disease Dermatologic conditions Traumatic brain injury Lyme disease and more. Volume 1 and Volume 2 have been edited by Linda Elsegood, founder of the UK-based LDN Research Trust. Through the Trust and her work on the LDN books, Linda has connected thousands of patients, doctors and pharmacists around the world with information, articles and patient stories about LDN. The LDN Book, Volume 2 is a fantastic resource for practitioners, pharmacists and patients and a renewed call for further research on the healing potential of this beneficial drug.Trade Review“Since the first volume of The LDN Book was released, I have had the distinct privilege of learning from and collaborating with the best clinicians and researchers in the field of integrative medicine. Through these collaborations, we continue to build upon the already vast applications of this low-dose but high-power medication. I am thrilled to see so many trusted colleagues, who have also become friends, contribute to this important body of work. Thank you, again, Linda Elsegood, for bringing together a tribe of like-minded people who continue to find solutions to challenging medical issues with this simple and inexpensive intervention.”—Dr. Nasha Winters, ND, FABNO, author of The Metabolic Approach to Cancer“As a pharmacist, I often wish for a ‘miracle’ drug that would be safe, effective, and inexpensive and could help the masses take back their health. While no drug is right for everyone, I have seen LDN transform the lives of countless people with autoimmunity. For some, LDN has truly been a miracle drug. I highly recommend both volumes of The LDN Book as valuable resources for patients and clinicians alike to explore the best practices for using LDN.”—Dr. Izabella Wentz, Pharm.D., FASCP, New York Times bestselling author of Hashimoto’s Protocol“A fantastic resource. All the latest research on low dose naltrexone and its various uses in clinical practice is compiled in this easy-to-use volume—The LDN Book, Volume 2. I will definitely be keeping this book in my office for reference.”—Jill C. Carnahan, MD, ABIHM, ABoIM, IFMCP“Even if you think you know about the benefits of LDN for certain conditions through practical experience or otherwise, this book will expand your understanding and amazement. It is a remarkable finding that a drug designed for a specific condition can be applied to so many other systems at lower and lower doses. Interestingly, this has shown us that many other drugs may also have unexpected benefits at lower-than-intended doses. There are many layers of complexity that remain to be uncovered!”—Dr. Angus Dalgleish, professor of oncology, St. George’s, University of London; principal, Institute for Cancer Vaccines and Immunotherapy (ICVI)“Over the years, a wealth of clinical trials and studies on LDN have given us better information about how and why LDN actually works. Through this research, we have uncovered many new uses of LDN in medical treatment. Reviewing The LDN Book, Volume 2 and seeing how other experts prescribe LDN in their clinics has been a great treat for me. My clinic, Clinic 158, has been prescribing LDN for 12 years. We have thousands of very happy patients who have found success with the medication for a myriad of ailments, and we are still learning new information.”—Dr. Andrew McCall, director, Clinic 158“Since inflammation is a major contributor to almost all chronic disorders, LDN therapy bridges nearly every medical specialty. In The LDN Book, Volume 2, the authors provide an excellent overview of LDN’s mechanism of action, review the vast evidence base supporting clinical applications, and, most importantly, report actual cases in which LDN was instrumental in the successful treatment of patients. This book is a must-have for every clinician, and LDN should be considered in the treatment of the many disorders outlined therein.”—Sahar Swidan, Pharm.D., R.Ph., ABAAHP, FAARFM, FACA, president and CEO, Pharmacy Solutions
£18.00
McGraw-Hill Education - Europe EMS Pocket Drug Guide 2E
Book SynopsisPublisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.SMALL ENOUGH TO FIT IN YOUR POCKET, DETAILED ENOUGH TO PROVIDE EVERYTHING YOU NEED TO KNOW Essential data on more than 1,000 of the most commonly used prescribed medications and more than 75 drugs most often used in the pre-hospital setting Drug-specific EMS pearls, including signs and symptoms of overdose and specific overdose management Sections on popular medicinal herbs and common street drugs Quick-reference tables encapsulate essential information Street Drug section updated to include "bath salts" and salvia Table of ContentsMedication KeyAbbreviationsEMS Field Medications: Prehospital Drug Classification Commonly Prescribed Medications: ClassificationCommonly Prescribed Medications: Generic and Selected Brand DataCommonly Used Medicinal HerbsCommon Street drugsTablesIndex
£16.14
Elsevier Health Sciences Biopharmaceutical Processing
Book SynopsisTable of Contents1. Overview of Biotherapeutics and Vaccine Industry 2. Industrial Process Design Concepts 3. Single-Use Concepts in Manufacturing 4. Equipment and Automation 5. Facility Design 6. Process Development Routines 7. Production Sources and their Selection 8. Upstream Processing 9. Downstream Processing 1: Recovery Process 10. Downstream Processing 2: Purification Process 11. Downstream Related Methods 12. Analytics 13. Regulatory Aspects 14. Manufacturing Operations 15. Economics
£232.90
Muscle 2Volume Set
Book Synopsis
£119.00
Elsevier Science Publishing Co Inc Nutraceuticals
Book SynopsisTable of ContentsSection I. Applications of nutraceuticals in common diseases and disorders 1. Nutraceuticals in central nervous system diseases: potential mechanisms of neuroprotection 2. Prevention of neurodegenerative disorders by nutraceuticals 3. Cognitive effects of nutraceuticals 4. Nutraceuticals in anxiety and stress 5. Countering cardiovascular diseases with nutraceuticals 6. Nutraceuticals for diabetes and glucose balance 7. Role of nutraceuticals in respiratory and allied diseases 8. Nutraceuticals in hepatic diseases 9. Nutraceuticals in renal diseases 10. Nutraceuticals in gastrointestinal disorders 11. Nutraceuticals in reproductive and developmental disorders 12. Nutraceuticals in ophthalmic diseases 13. Nutraceuticals in dermal diseases 14. Nutraceuticals in arthritis 15. Nutraceuticals in sports activities and fatigue 16. Role of nutraceuticals as adaptogens 17. Nutraceuticals for weight loss 18. Nutraceuticals in cancer prevention 19. Application of “nano nutraceuticals in medicine Section II. Models and mechanisms in evaluation of nutraceuticals 20. The biology of nutrients: genetic and molecular principles 21. Genomic and proteomic mechanisms and models in toxicity and safety evaluation of nutraceuticals 22. Transcriptomic profiling for safety and toxicity evaluation of nutraceuticals 23. Target identification and polypharmacology of nutraceuticals 24. Systems pharmacology investigation of mechanism of action of nutraceuticals 25. Noninvasive in vivo optical imaging models for safety and toxicity testing 26. Flow cytometry and light-scattering techniques in evaluation of nutraceuticals 27. Zebrafish as a model system to evaluate the safety and toxicity of nutraceuticals 28. Caenorhabditis elegans: an elegant model organism for evaluating the neuroprotective and neurotherapeutic potential of nutraceuticals 29. Alternative in vitro models for safety and toxicity evaluation of nutraceuticals 30. Mitochondria as a target for safety and toxicity evaluation of nutraceuticals 31. Oxidative stress and excitotoxicity: antioxidants from nutraceuticals Section III. Common nutraceuticals 32. Caffeine: an evaluation of the safety database 33. Biological activities and potential nanotechnological delivery of resveratrol 34. Melatonin: a safe nutraceutical and clinical agent 35. Standardized turmeric and curcumin 36. Curcuminoid-metal complexes for oxidative stress 37. Fenugreek: multiple health benefits 38. Cannabis sativa: an overview 39. Cannabidiol safety 40. St John’s wort (Hypericum perforatum L) 41. Green tea 42. Green coffee beans 43. Quercetin 44. German chamomile 45. Isoflavones: toxicological aspects and efficacy 46. Propolis 47. Bee products as nutraceuticals to nutraceuticals for bees 48. Ginkgo biloba 49. Chinese ginseng 50. Ashwagandha: multiple health benefits 51. Astaxanthin: health benefits and toxicity 52. Thymoquinone 53. Glucosinolates 54. Organosulfur compounds as nutraceuticals 55. Arginine and citrulline as nutraceuticals: efficacy and safety in diseases 56. Neem Extract 57. Spirulina 58. Garcinia cambogia 59. Vitamin E TPGS and its applications in nutraceuticals 60. Role of transferrin: an iron-binding protein in health and diseases 61. Glutamine supplementation: hope, hype, or stay tuned? 62. What to do with placenta after birth: is it a waste? 63. Chitin, chitosan, and their derivatives Section IV. Prebiotics and probiotics 64. Prebiotics: safety and toxicity considerations 65. Probiotics: safety and toxicity considerations 66. Synbiotics: safety and toxicity considerations Section V. Nutraceuticals in veterinary medicine 67. Nutraceuticals in animal health and diseases Section VI. Toxicity and toxic interactions 68. Toxic contamination of nutraceuticals and food ingredients 69. Nutraceuticals and adverse outcome pathways 70. Interactions between nutraceuticals/nutrients and nutrients and therapeutic drugs 71. Genotoxicity evaluation of nutraceuticals Section VII. Regulatory aspects 72. The regulatory framework for nutraceuticals: North America 73. Evaluation and regulation of food supplements: European perspective 74. Regulatory guidelines for nutraceuticals in India: an overview 75. Regulatory aspects of nutraceuticals: Chinese perspective 76. Uses and regulation of nutraceuticals: Australia and New Zealand 77. Regulatory aspects of nutraceuticals: Japanese perspective 78. Nutraceuticals: the Turkish perspective
£131.75
Pearson Education Student Workbook for Focus on Pharmacology
Book SynopsisThe completely revised and expanded Student Workbook offers readers more practice and review opportunities that are tied to the learning goals in Focus on Pharmacology: Essentials for Health Professionals , Third Edition. The Workbook contains many different types of review questions, including multiple-choice, fill-in-the-blank, true/false, and critical-thinking.
£50.09
Tarcher/Putnam,US Complete Guide to Prescription Nonprescription
Book Synopsis
£22.50
Oxford University Press, USA Stimulant Drugs and ADHD Basic and Clinical Neuroscience
Book SynopsisStimulant drugs are widely used in the treatment of ADHD in children and adults, yet their mechanism of action have been poorly understood. This volume integrates advances in the basic and clinical neurosciences in order to shed light on this question.Trade Review"This book is an ambitious, even courageous, attempt to pull together evidence from the basic and clinical neurosciences that may ultimately help explain how stimulant drugs act to reduce the behavioral and cognitive symptoms associated with attention-deficit-hyperactivity disorder (ADHD)." --Contemporary Psychology "This book is an ambitious, even courageous, attempt to pull together evidence from the basic and clinical neurosciences that may ultimately help explain how stimulant drugs act to reduce the behavioral and cognitive symptoms associated with attention-deficit-hyperactivity disorder (ADHD)." --Contemporary Psychology "...a volume that will interest almost anyone who works with attention deficit hyperactivity disorder (ADHD) in either clinics or research programs"--The Journal of Nervous and Mental Disease "...a timely addition to the ever growing literature on the most controversial of pharmacotherapies for children and adolescents...most of the chapters are engaging....The clinical chapters by Mary Solanto(on the clinical features of ADHD), Laurence Greenhill(on the clinical effects of stimulant medication), and the final, challenging chapet by Solanto, Amy Arnsten, and Xavier Castellanos are outstanding."--The Lancet, 2001 "This slender volume is an excellent collection of reviews on ADHD in the context of modern psychopharmacology and neuroscience....The quality of all the chapters is consistently of a very high standard, each text a gem on its own. They are concisely written and densely packed with relevant information. The materials are accessible, despite being technical in nature...a superb set of essays....Overall, this is--and I believe will remain for some time--a benchmark publication, relevant to any clinician who prescribes ADHD psychopharmacological treatment, and to investigators in ADHD research from medical or neuroscience backgrounds alike."--Journal of Child Psychology and PsychiatryTable of ContentsPART I: PHENOMENOLOGY; PART II: BASIC NEUROSCIENCE; PART III: CLINICAL NEUROSCIENCE; PART IV: INTEGRATION
£101.25
Oxford University Press Triumph of the Heart
Book SynopsisOver 25 million people in the U.S. alone have benefited from statins--such drugs as Lipitor, Zocor, Crestor, Pravachol, and other cholesterol-lowering medicines--in preventing stroke, heart attack, and other forms of coronary heart disease. But how did these remarkable, life-saving drugs come into being? In Triumph of the Heart, Dr. Jie Jack Li, a medicinal chemist and expert on drug discovery, tells for the first time the fascinating story of statins. Drawn from interviews with many scientists involved in the discovery and development of these drugs, the book illuminates the human side of science by revealing the role played by persistence, luck, and sudden insight that characterize major discoveries. For scientists in the drug industry, health care professionals, students of medicine, and all those intrigued by the basic human drive to explore and discover, Triumph of the Heart offers a compelling view of one of the most important drug discoveries of our time.Trade ReviewThis book offers valuable insights into the way a drug company goes about building a platform for a potential "blockbuster". * Lancet *You do not need to be a chemist or scientist to understand this book. It is easy to read, engaging and educational. * Laura Strachan, Nursing Standard *Table of ContentsPROLOGUE ; APPENDIX ; TRADEMARKS OF THE DRUGS ; BIBLIOGRAPHY AND NOTES ; INDEX
£39.59
Oxford University Press An Introduction to Drug Synthesis
Book SynopsisAn Introduction to Drug Synthesis explores the central role played by organic synthesis in the process of drug design and development.Written by an experienced and talented author to complement his existing An Introduction to Medicinal Chemistry, the book illustrates how organic synthesis makes important contributions throughout the drug design and discovery process - from the generation of novel drug structures to the improved efficiency of large scale synthesis.Avoiding excessively detailed descriptions of the underlying synthetic pathways, the book focuses on how synthesis can be used in a strategic way - how and why different synthetic approaches are adopted, and the pros and cons of each. With examples used extensively to illustrate the concepts presented, An Introduction to Drug Synthesis> is the ideal resource for any pharmaceutical or medicinal chemistry student who needs a thorough understanding of how the concepts of organic synthesis are applied to the development of therapeutic drugs.Online ResourcesAn Introduction to Drug Synthesis is supported by online resources featuring:For registered adopters:- Figures from the book in electronic format;For students:- A suite of multiple-choice questions to support the learning process;- Additional case studies- More detailed descriptions of key synthetic reactions, as a source of further reference.Trade ReviewThis is a well-written guide to many of the key concepts in the application of organic synthesis to drug discovery and development. * Doody's Notes *Table of ContentsPART A: Concepts ; 1. The drug discovery process ; 2. Drug synthesis ; 3. Retrosynthesis ; 4. Cyclic systems in drug synthesis ; 5. The synthesis of chiral drugs ; 6. Combinatorial and parallel synthesis ; PART B: Applications of drug synthesis in the drug development process ; 7. Synthesis of lead compounds ; 8. Analogue synthesis in drug design ; 9. Synthesis of natural products and their analogues ; 10. Chemical and process development ; 11. Synthesis of isotopically labelled compounds ; PART C: Design and synthesis of selected antibacterial agents ; 12. Design and synthesis of tetracyclines ; 13. Erythromycin and macrolide antibacterial agents ; 14. Quinolones and fluoroquinolones
£47.49
Oxford University Press Drug Design and Development
Book SynopsisDrug Design and Development outlines the processes involved in the design and development of new drugs and emphasises the significance of these processes to the practice of pharmacy. The book highlights why it is important that all practicing pharmacists, including those working in hospitals or high street stores, have a solid understanding of the process of the design and development of the drugs they interact with. It adopts an integrated approach, formulated to complement courses which are designed in line with the General Pharmaceutical Council''s new curriculum requirements. Furthermore, this is the only integrated textbook to consider both drug design and development within one volume. Throughout the book, the journey of the drug, from discovery to market, is presented in an integrated fashion, emphasising the interconnection of all the processes involved.Trade ReviewWell written text that guides students through the complex elements of the drug development process. It has a chemistry focus and utilises 'key points' to reinforce the important aspects at regular opportunities. * Dr James F. Brown, University of Portsmouth *Table of Contents1: Introduction Part 1 Drug targets 2: Receptors and signal transduction 3: Enzymes as drug targets 4: Nucleic acids and protein synthesis as drug targets 5: Other drug targets Part 2 Origins of drug molecules 6: Sources of lead compounds 7: Drug synthesis 8: Optimisation of lead compounds 9: Computer-aided drug design 10: Combinatorial chemistry and high-throughput screening 11: Biotechnology and biopharmaceuticals Part 3 Biological aspects of drug development 12: Drug metabolism 13: Pharmacogenetics and pharmacogenomics 14: Toxicity testing Part 4 Preformulation studies 15: Solubility and drug development 16: Solid state characteristics 17: Drug stability Part 5 Clinical research 18: Clinical research and its regulation 19: Design and management of clinical trials
£37.99
Oxford University Press Oxford Handbook of Prescribing for Nurses and
Book SynopsisThe new revised third edition of the Oxford Handbook of Prescribing for Nurses and Allied Health Professionals, provides concise, practical, and expert guidance on all aspects of non-medical prescribing. Now thoroughly updated, key advice has been organised by practice specialty, to aid learning and decision making in prescribing practice, and ensure the vital information is always at your fingertips. Using information from the authors'' years of experience as nurse practitioners and teachers, this practical handbook is packed with a wealth of recommendations, guidance, and support. Containing the practical principles nurses and other non-medical prescribers need to practice safely, effectively and cost-consciously whatever the situation, it provides evidence-based advice on a wide selection of subjects to give a complete picture of the role of the prescriber. The topics covered range from basic pharmacology, to the legal aspects and processes of prescribing practice, as well as prescribing for specific conditions and special groups, such as the older person and the very young.This new edition features the most recent legislation and changes to prescribing standards, giving nurses and non-medical prescribers access to the most up-to-date information to inform their practice. This new edition has been reorganised to focus on the most common scopes of practice, for both acute and long conditions frequently managed by NMPs, to ensure ease-of-access to essential information.Written by practising nurses and checked by subject experts and pharmacologists, the Oxford Handbook of Prescribing for Nurses and Allied Health Professionals, third edition continues to be an essential companion for all nurse and non-medical prescribers. It is ideal for students taking prescribing courses as a detailed and practical guide to practice as it covers all the competency areas, through to established practitioners who would like a handy reference to dip into when needed, as well as for other non-medical prescribers.
£28.49
Oxford University Press Understanding Antiepileptic Drugs
Book SynopsisWritten by two world experts, Understanding Antiepileptic Drugs describes the profiles of all current antiepileptic drugs comprehensively with all side effects. Understandable and well organized this book is unique in its kind and crucial for both patients and health café professionals dealing with epilepsy.Trade Review"There is an enormous need to provide essential information regarding medications available to people with epilepsy and to their caregivers. This book is an excellent tool attempting to address a gap in our ability to communicate with people with epilepsy by providing information that will help them understand how the medications work, the dosing, as well as the side effects. Understanding Antiepileptic Drugs is written in an easy to read manner, and provides extremely valuable information that will benefit all people with epilepsy." --Solomin L. Moshe, MD, Charles Frost Chair in Neurosurgery and Neurology, Professor of Neurology, Neuroscience & Pediatrics, Director Pediatric Neurology, Director Clinical Neurophysiology, Albert Einstein College of Medicine, and Past President ILAE (2009-2013), New York, NYTable of ContentsForeword 1st English Edition ; Foreword 5th German Edition ; Preface ; Introduction ; Patient Recommendations ; Generic Drugs ; Slow Release Drugs ; Orphan Drugs ; 1. Carbamazepine ; 2. Clobazam ; 3. Eslicarbazepine acetate ; 4. Ethosuximide ; 5. Felbamate ; 6. Gabapentine ; 7. Lacosamide ; 8. Lamotrigine ; 9. Levetiracetam ; 10. Oxcarbazepine ; 11. Perampanel ; 12. Phenobarbital / Primidone ; 13. Phenytoin ; 14. Pregabalin ; 15.Retigabine ; 16.Rufinamide ; 17. Stiripentol ; 18. Tiagabine ; 19. Topiramate ; 20. Valproic Acid ; 21. Vigabatrin ; 22. Zonisamide
£17.57
Oxford University Press Top Drugs
Book SynopsisDrugs like Lipitor, Plavix, Taxol, and Zoloft are integral in today''s medicinal world. These widely used products save lives and improve the quality of lives, playing a crucial role in everything from cholesterol management to cancer treatment. These advances in medicine were brought into existence after nuanced process of creation, featuring a wide range of chemical and pharmacological experimentation and discovery.Top Drugs: Their History, Pharmacology, and Synthesis provides an in-depth study on ten prominent drugs, outlining the chemistry behind each one''s creation. Jie Jack Li, a medicinal chemist and an expert on drug discovery, offers a thorough analysis of the landscape of current drug development. The comprehensive text is divided by health issues, including cardiovascular, cancer, metabolic diseases, and infectious diseases. Each section features individual chapters on significant drugs, outlining the chemistry and history of the drug''s discovery. Li begins each chapter wiTrade Review"This book will interest students and scientists in disciplines such as chemistry, biology, pharmacology, toxicology, clinical medicine, and biotechnology, as well as informed general audiences. Recommended." --CHOICETable of ContentsTable of Contents ; CARDIOVASCULAR DRUGS ; Chapter 1 Atorvastatin Calcium (Lipitor) ; Chapter 2 Clopidogrel (Plavix) ; Chapter 3 Amlodipine (Novasc) ; CANCER DRUGS ; Chapter 4 Paclitaxel (Taxol) ; Chapter 5 Imatinib (Gleevec) ; DRUGS FOR METABOLIC DISEASES ; Chapter 6 Sitagliptin (Januvia) ; CNS DRUGS ; Chapter 7 Sertraline (Cymbalta) ; Chapter 8 Olanzapine (Zyprexa) ; DRUGS TO TREAT INFECTIOUS DISEASES ; Chapter 9 Sofosbuvir (Sovaldi) ; ULCER DRUGS ; Chapter 10 Esomeprazole (Nexium)
£40.49
Oxford University Press Oxford Handbook of Practical Drug Therapy
Book SynopsisThis Handbook mirrors the leading national guides to prescribing. The safe and effective use of medicine requires a sound knowledge of pharmacology. As readers use this practical book, they will increase their knowledge.Trade ReviewI would recommend the Oxford Handbook of Practical Drug Therapy for both use on the wards and for revision for medical school exams. . . Its in depth cover of relevant prescribing information will make it a useful resource for junior doctors as well as medical students. * Lucy Faulkner, Northwing Magazine Sheffield University Medical Students Magazine *This is a small compact and easy to utilise drug therapy manual. Overall a well set out easy to follow guide that would be useful for health professionals of all levels. * ANTS Bulletin *Table of ContentsIntroductory sections ; 1. Gastrointestinal system ; 2. Cardiovascular system ; 3. Respiratory system ; 4. Central nervous system ; 5. Infections ; 6. Endocrine system ; 7. Kidneys and the urinary tract ; 8. Malignant disease and immunosuppression ; 9. Nutrition and blood ; 10. Musculoskeletal and joints ; 11. Eye ; 12. Skin ; 13. Poisoning ; 14. Immunological products and vaccines ; 15. Relief of pain and anaesthetic drugs
£32.29
Oxford University Press Blockbuster Drugs
Book SynopsisBlockbuster drugs-each of which generates more than a billion dollars a year in revenue-have revolutionized the industry since the early 1980s, when sales of Tagamet alone transformed a minor Philadelphia-based firm into the world''s ninth-largest pharmaceutical company. In Blockbuster Drugs, Jie Jack Li tells the fascinating stories behind the discovery and development of these highly lucrative medicines, while also exploring the tumult the industry now faces as the patent cliff nears. Having spent most of his career in drug research and development, Li brings an insider''s eye to the narrative as he recounts the tales of discovery behind such drugs as Tagamet, Zantac, Claritin, Prilosec, Nexium, Serouquel, Plavix, and Ambien. As he discusses each breakthrough, Li also shows that scientific research is filled with human drama-serendipitous discoveries, sudden insights, tense confrontations. For instance, the author tells of James Black, who persisted in the research that led to TagameTrade ReviewRecipient of the 2015 Alpha Sigma Nu Book Award. "Once again, with his latest book, Jack Li has produced a wonderfully fascinating and rich history of the so-called 'Blockbuster Drugs.' From the treatment of ulcers and acid reflux, to the control of allergies, and the conquest of pain, Dr. Li weaves a beautiful tale of these extraordinary medicines, familiar to all. The book is full of detail, with an extensive bibliography, and, for the molecular connoisseur, includes chemical structures in the Appendix. Dr. Li is rapidly becoming a premiere figure for writing about medicines for the educated population!" -- Gordon W. Gribble, The Dartmouth Professor of Chemistry, Dartmouth University "This enjoyable book describes more than a century of progress in the development of many major new medicines for the treatment of human illness. It provides deep insights into the process of innovation and also the remarkable individuals responsible for it. The accounts are understandable to the non-scientist but also valuable to researchers and practitioners of modern medicine. There is a nice balance between the human, historical and medical sides of drug discovery -- one of the most consequential activities of our times." -- E.J. Corey, Nobel Laureate, Harvard University "Jie Jack Li takes us through the ages of pharmaceuticals in this informative and engaging book. Professor Li links the medical world with its much broader cultural background in a way that will appeal to many. If you are interested in the past, present, and future of the medicines you take and the background to their production, look no further than this book." --New York Journal of BooksTable of ContentsTable of Contents ; Chapter 1 Before the Age of Blockbuster Drugs ; Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet ; Chapter 3 More Blockbuster Drugs for Ulcer ; Chapter 4 Antihistamines as Allergy Medicines ; Chapter 5 Blood Thinners, From Heparin to Plavix ; Chapter 6 Conquest of Pain-Analgesics: from Morphine to Lyrica ; Chapter 7 Lessons ; Bibliography ; Appendix ; Index
£38.69
The University of Chicago Press Vaccine Nation Americas Changing Relationship
Book Synopsis
£17.00
The University of Chicago Press Therapeutic Revolutions Pharmaceuticals and
Book SynopsisWhen asked to compare the practice of medicine today to that of a hundred years ago, most people will respond with a story of therapeutic revolution: back then we had few effective remedies, now we have more (and more powerful) tools to fight disease, from antibiotics to psychotropics to steroids to anticancer agents. This collection challenges the historical accuracy of this revolutionary narrative and offers instead a more nuanced account of the process of therapeutic innovation and the relationships between the development of medicines and social change. These assembled histories and ethnographies span three continents and use the lived experiences of physicians and patients, consumers and providers, and marketers and regulators to reveal the tensions between universal claims of therapeutic knowledge and the actual ways they have been used and understood in specific sites, from postwar West Germany pharmacies to twenty-first century Nigerian street markets. By asking us to rethink
£95.00
The University of Chicago Press Therapeutic Revolutions
Book Synopsis
£33.25
The University of Chicago Press Synthesizing Hope
Book Synopsis
£68.40
The University of Chicago Press Synthesizing Hope
Book Synopsis
£22.80
Columbia University Press The Risks of Prescription Drugs
Book SynopsisTrade ReviewThe Risks of Prescription Drugs explains in clear, concise, and unflinching language the consequences of ignoring the discrepancy between the drug industry's private interests and the public service we hope and naively expect from them. This book provides consumers with tools for self-defense and concerned citizens with a road map for rebalancing American medicine. -- John Abramson, Harvard Medical School, author of Overdosed America: The Broken Promise of American Medicine This volume introduces important debates on pharmaceutical promotion and marketing, needed drug evaluation and regulation, professional conflicts of interest, and increased medicalization of behavior. It explores important trends and policy questions that all engaged citizens should consider. -- David Mechanic, Rutgers Institute for Health, Health Care Policy, and Aging Research, and author of The Truth About Health Care: Why Reform Is Not Working in America This is a sensible, readable and constructive book that could in various respects open the reader's eyes, and then lead him, with his eyes wide open, along the road to a healthier world. -- M.N.G. Dukes International Journal of Risk and Safety in Medicine This well-referenced title will be of particular interest to prescribers, but I recommend it to all healthcare professionals. -- Roger Evans Nursing StandardTable of Contents1. Bearing the Risks of Prescription Drugs, by Donald W. Light 2. The Food and Drug Administration: Inadequate Protection from Serious Risks, by Donald W. Light 3. The Commercialization of Medical Decisions: Physicians and Patients at Risk, by Howard Brody 4. Pharmaceuticals and the Medicalization of Social Life, by Allan V. Horwitz 5. Medicalization and Risk Scares: The Case of Menopause and HRT, by Cheryl Stults and Peter Conrad Epilogue. Toward Safer Prescribing and Better Drugs, by Donald W. Light List of Contributors
£49.50
Columbia University Press The Quest for the Cure
Book SynopsisTrade ReviewThe dearth of promising new treatments for many a serious disease remains a major challenge not just for the pharmaceutical industry but for all of society. In this exhaustively researched book, Brent R. Stockwell surveys the history of drug development and offers insightful suggestions for innovative new approaches. This is critical reading for the many involved in and concerned about this urgent issue. -- Robert Bazell, chief science correspondent, NBC News, and author of Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer This is a terrific book! Stockwell's writing is clear and engaging as he presents a thoughtful analysis of drug development that can be understood and appreciated by a diverse readership. Stockwell beautifully combines scientific history and personal anecdotes with clear explanations of the principles and practices of chemical biology to make a fascinating story of the past, present, and future of drug discovery. His book is informative, accurate, and a good read all put together. -- Geoffrey Cooper, Boston University, author of The Cell: A Molecular Approach and Oncogenes This is a truly wonderful book. Stockwell's writing will open the door to a universe that many readers may know little about. Drugs are born, biotech companies are created, scientists' careers are made and unmade, egos are raised and dashed. This book is so readable, it is an absolute page-turner. Yet it is also authoritative and scientifically sophisticated, managing to distill a complex, changing field into a beautifully written, well-crafted story. -- Siddhartha Mukherjee, Columbia University, author of The Emperor of All Maladies: A Biography of Cancer By providing accessible explanations for the underlying biological and chemical principles that apply to the complex solutions he describes, Stockwell enables even the scientifically unsophisticated reader to gain a wider perspective on what future disease treatment might entail. Publishers Weekly This very readable, even exciting work takes us through the medical breakthroughs of the past century. Globe and Mail This book deserves a readership, and there is certainly a need for it. As a drug companyresearcher, I have often wished that more people understood what the field was likeand how simultaneously fascinating and frustrating it can be. -- Derek B. Lowe Cell In this well-researched look into the complexities of making medicines, a chemical biologist gives a history of drug making and details innovative methods of drug discovery. Science News Despite our current political paralysis, government leaders should listen to Stockwell and be certain to advance our capacity to generate the drugs that our society and the world need. Harvard Magazine The book is well organized and includes many interesting, clever analogies to explain what can be complicated scientific problems. Choice An engaging and rewarding read... -- Donald C. Lo Journal of Clinical Investigation The reader is not only left with a satisfying overview of the proud history and future challenges of finding new medicines but also encouragement that Stockwell and his contemporaries are creatively committed to academic drug discovery. -- David Kroll Nature Chemistry Stockwell writes well-his prose is accessible to the educated reader, irrespective of his or her background. All of the personalities, errors and successes in contemporary drug discovery are presented. Stockwell enlivens their stories with anecdotes... -- Garrett A. FitzGerald Nature Medicine It is impossible to read this relatively short book...without being captured by the author's optimism about the future of drug development. -- Robert C. Young, M.D. Oncology TimesTable of ContentsList of Illustrations Preface Acknowledgments Abbreviations Part I. The Vanishing Cures 1. The Drug Discovery Crisis 2. A New Science of Molecules 3. The Birth of the First Cancer Drugs 4. A New Company Creating Drug Combinations 5. The Undruggable RAS Protein 6. The Druggable Genome Part II. The Path to the Next Generation of Medicines 7. Peering Inside Proteins 8. The Nature of Interactions Between Proteins 9. From Protein-Protein Interactions to Personalized Medicines 10. A Revolution in Peptide Synthesis 11. A Vast Array of Drug Candidates 12. Moving Outside the Small Molecule Box 13. Accelerating the Arrival of Next-Generation Drugs Notes Glossary Index
£23.80
Dorling Kindersley Ltd New Guide to Medicine and Drugs
Book Synopsis
£17.99
MIT Press Ltd Cannabinoids and the Brain The MIT Press
Book SynopsisA review of the scientific evidence on the effects of cannabinoids on brain and behavioral functioning, with an emphasis on potential therapeutic use.The cannabis plant has been used for recreational and medicinal purposes for more than 4,000 years, but the scientific investigation into its effects has only recently yielded useful results. In this book, Linda Parker offers a review of the scientific evidence on the effects of cannabinoids on brain and behavioral functioning, with an emphasis on potential therapeutic uses.Parker describes the discovery of tetrahydocannbinol (THC), the main psychoactive component of cannabis, and the further discovery of cannabinoid receptors in the brain. She explains that the brain produces chemicals similar to THC, which act on the same receptors as THC, and shows that the endocannabinoid system is involved in all aspects of brain functioning. Parker reports that cannabis contains not only the psychoactive compound THC, but also
£18.99
Yale University Press Tamoxifen and Breast Cancer
Book SynopsisA discussion of the diagnosis of breast cancer and the risks, benefits and limitations of treatment alternatives, particularly tamoxifen. This edition contains information on developments in the use of tamoxifen, especially in the results of the Breast Cancer Prevention Trial.
£21.67
Elsevier - Health Sciences Division Pharmacology Flash Cards
Book SynopsisTable of ContentsPharmacology Flash Cards Fourth Edition Section I: Autonomic, Autacoid, and Neuromuscular Drugs Section II: Cardiovascular Drugs Section III: Lipid, Coagulation, and Hematopoiesis Drugs Section IV: Central Nervous System Depressant Drugs Section V: Psychotherapeutic Drugs Section VI: Analgesic and Antimigraine Drugs Section VII: Neurodegenerative Disease Drugs and Antidotes Section VIII: Anesthetic Drugs Section IX: Gastrointestinal Drugs Section X: Respiratory Drugs and Antihistamines Section XI: Musculoskeletal Drugs Section XII: Endocrine Drugs Section XIII: Antibacterial Drugs Section XIV: Antifungal, Antiviral, and Antiparasitic Drugs Section XV: Antineoplastic And Immunosuppressant Drugs
£35.14
Elsevier - Health Sciences Division Study Guide for Understanding Pharmacology
Book SynopsisTable of ContentsUNIT I: General Aspects of Pharmacology 1. Drug Regulation, Actions, and Responses 2. Safely Preparing and Giving Drugs UNIT II: Mathematics for Pharmacology and Dosage Calculation 3. Mathematics Review and Introduction to Dosage Calculations 4. Medical Systems of Weights and Measures 5. Dosage Calculation of Intravenous Solutions and Drugs UNIT III: Pharmacology For Multisystem Application 6. Anti-Inflammatory Drugs 7. Drugs for Pain Control 8. Anti-Infectives: Antibacterial Drugs 9. Anti-Infectives: Antiviral Drugs 10. Anti-Infectives: Antitubercular and Antifungal Drugs 11. Immunizations 12. Anticancer Drugs Unit IV: Drug Therapy for Endocrine Problems 13. Drug therapy for Diabetes 14. Drug Therapy for Thyroid and Adrenal Gland Problems Unit V: Drug Therapy for Problems of the Circulatory and Cardiac Systems 15. Drug Therapy Affecting Urine Output 16. Drug Therapy for Hypertension 17. Drug Therapy for Heart Failure 18. Drug Therapy for Dysrhythmias 19. Drug Therapy for High Blood Lipids 20. Drug Therapy to Disrupt Clotting Unit VI: Drug Therapy for Respiratory System Problems 21. Drug Therapy for Asthma, Chronic Obstructive Pulmonary Disease, and Pulmonary Fibrosis/Hypertension Unit VII: Drug Therapy for Gastrointestinal System Problems 22. Drug Therapy for Gastrointestinal Dysfunction 23. Drug Therapy for Gastric Ulcers and Reflux 24. Drug Therapy with Nutritional Supplements Unit VIII: Drug Therapy for Nervous System Problems 25. Drug Therapy for Seizures 26. Drug Therapy for Parkinson's and Alzheimer's Diseases 27. Drug Therapy for Psychiatric Problems 28. Drug Therapy for Insomnia 29. Drug Therapy for Eye Problems Unit IX: Drug Therapy for Problems of the Musculoskeletal System 30. Drug Therapy for Osteoporosis and Muscle Relaxation Unit X: Drug Therapy for Problems of the Reproductive System 31. Drug Therapy for Male Reproductive Problems 32. Drug Therapy for Female Reproductive Problems Glossary Index
£29.44
Elsevier - Health Sciences Division Pharmacy Management Software for Pharmacy
Book Synopsis
£114.94
Elsevier - Health Sciences Division Emerging Nanotechnologies for Diagnostics Drug
Book SynopsisTable of Contents1. Therapeutic Applications of Polymeric Materials 2. Multifunctional Micro- and Nanoparticles 3. Nanomicelles in Diagnosis and Drug Deliver 4. Diagnosis and Drug Delivery to the Brain: Novel Strategies 5. Emerging Nanotechnology for Stem Cell Therapy 6. Nanoparticulate Systems for Therapeutic and Diagnostic Applications 7. Peptide and Protein-Based Therapeutic Agents 8. Nanotechnology in Intracellular Trafficking, Imaging, and Delivery of Therapeutic Agents 9. Electrospun Nanofibers in Drug Delivery: Fabrication, Advances, and Biomedical Applications 10. Nanosystems for Diagnostic Imaging, Biodetectors, and Biosensors 11. Micro- and Nanotechnology-Based Implantable Devices and Bionics 12. Solid Lipid Nanoparticles in Drug Delivery: Opportunities and Challenges 13. Microneedles in Drug Delivery 14. Nanotechnology-Based Medical and Biomedical Imaging for Diagnostics 15. Drug and Gene Delivery Materials and Devices
£112.50
Elsevier - Health Sciences Division Brodys Human Pharmacology
Book SynopsisTable of ContentsSection 1 Mechanisms of Drug Action and Therapeutic Principles 1. Introduction, Terminology 2. Pharmacodynamics: Drug Targets (Receptors, Enzymes, DNA, etc) 3. Pharmacokinetics 4. Pharmacogenomics 5. Drug Discovery, Development, and Regulation Section 2 Chemical Mediators and Drugs Affecting Autonomic and Neuromuscular Synapses 6. Introduction to the Peripheral Nervous Systems and Drugs for Peripheral Disorders Cholinergic Drugs 7. Muscarinic Agonists and Their Clinical Uses 8. Muscarinic Antagonists and Their Clinical Uses 9. Nicotinic Agonists and Their Clinical Uses 10. Nicotinic Antagonists and Neuromuscular Blocking Drugs Adrenergic Drugs 11. Adrenergic Agonists and Their Clinical Uses 12. Adrenergic Antagonists and Their Clinical Uses Section 3 Drug Treatment for Disorders Affecting the Central Nervous System 13. Introduction to the CNS and Drugs Affecting the Brain Neurodegenerative Disorders 14. Drug Therapy for Alzheimer's Disease and Other Cognitive Disorders/Dementias 15. Pharmacotherapy of Basal Ganglia Disorders: Parkinson's Disease and Huntington's Disease 16. Drug Therapy for Psychoses and Bipolar Disorder 17. Drug Therapy for Depression and Anxiety 18. Drug Therapy for the Management of Attention Deficit Hyperactivity Disorder 19. Drug Therapy for Insomnia and the Hypersomnias 20. Drug Therapy for Managing Obesity and Eating Disorders 21. Treatment of Seizure Disorders 22. Drug Therapy to Control Spasticity Disorders 23. Ethanol, Other Alcohols, and Drugs for Alcohol Use Disorder 24. Illicit Psychoactive Compounds and Substance Use Disorder Section 4 Drug Therapy for Pain Management 25. Introduction 26. General Anesthetics 27. Local Anesthetics 28. Opioid Analgesics 29. Nonsteroidal Anti-inflammatory Agents and Acetaminophen 30. Cannabinoids Section 5 Treatment of Inflammatory, Allergic and Immunologic Disorders 31. Drug Therapy for Migraine Headache 32. Drug Therapy for Gout and Hyperuricemia 33. Drug Treatment for Allergic Reactions 34. Immunosuppressants for Autoimmune Disorders and Organ Transplantation 35. Drug Therapy for Rheumatoid Arthritis Section 6 Drug Treatment for Cardiovascular Diseases 36. Introduction to The Cardiovascular System and the Regulation of Blood Pressure and Heart Rate 37. Overview of Hypertension Management and Drugs that Decrease Sympathetic Tone 38. Diuretics and Drugs that Affect Volume and Electrolyte Content 39. Drugs Affecting the Renin-Angiotensin-Aldosterone System 40. Calcium Channel Blockers 41. Vasodilators 42. Drug Therapy for Hyperlipidemias and Atherosclerotic Cardiovascular Disease 43. Drug Therapy for Myocardial Ischemia and Angina Pectoris 44. Treatment of Heart Failure: Cardiac Glycosides, Phosphodiesterase Inhibitors and Other Agents 45. Antiarrhythmic Drugs 46. Anticoagulant, Antiplatelet and Thrombolytic Agents 47. Drug Therapy for Hemophilia and the Anemias Section 7 Treatment of Endocrine Disorders 48. Introduction to Endocrine Pharmacology 49. Treatment of Hypothalamic and Pituitary Disorders 50. Treatment of Adrenalcorticosteroid Disorders 51. Female Hormone Regulation 52. Androgens, antiandrogens and their clinical uses 53. Drug Therapy for the Management of Diabetes 54. Drug Therapy for the Management of Thyroid Disorders 55. Calcium Regulating Hormones and Agents Affecting Bone Section 8 Chemotherapy Infectious Diseases 56. Principles of Antimicrobial Use 57. Bacterial Cell Wall Synthesis Inhibitors 58. Inhibitors of Protein Synthesis 59. Drugs that Target DNA 60. Antimycobacterial Drugs and the Treatment of Tuberculosis and Leprosy 61. Drug Therapy for Resistant Organisms Parasitic Diseases 62. Antifungal Agents 63. Antimalarial and Other Antiprotozoal Agents 64. Antihelmintics Viruses 65. Drug Therapy for non-HIV Viral Infections 66. Drugs for HIV and Related Opportunistic Infections Cancer 67. Introduction and Therapeutic Principles 68. Cytotoxic Agents 69. Targeted Agents Section 9 Special Considerations 70. Therapeutic Use of Hematopoietic Growth Factors, Vitamins and Minerals 71. Gastrointestinal Disorders and Their Treatment 72. Pharmacological Treatment of Asthma and COPD 73. The Role of Neutraceuticals and Natural Products 74. Essentials of Toxicology 75. Therapeutic Considerations for Pregnant, Pediatric, Geriatric and Obese Individuals
£56.99
Elsevier - Health Sciences Division Raus Respiratory Care Pharmacology
Book SynopsisTable of ContentsUnit I: Basic Concepts and Principles in Pharmacology 1. Introduction to Respiratory Care Pharmacology 2. Principles of Drug Action 3. Administration of Aerosolized Agents 4. Calculating Drug Doses 5. The Central and Peripheral Nervous Systems Unit II: Drugs Used to Treat the Respiratory System 6. Adrenergic (Sympathomimetic) Bronchodilators 7. Anticholinergic (Parasympatholytic) Bronchodilators 8. Xanthines 9. Mucus-Controlling Drug Therapy 10. Surfactant Agents 11. Corticosteriods in Respiratory Care 12. Nonsteroidal Antiasthma Agents 13. Aerosolized Antiinfective Agents 14. Antimicrobial Agents 15. Cold and Cough Agents 16. Selected Agents of Pulmonary Value 17. Neonatal and Pediatric Aerosolized Drug Therapy Unit III: Critical Care, Cardiovascular, and Polysomnography Agents 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents) 19. Diuretic Agents 20. Drugs Affecting the Central Nervous System 21. Vasopressors, Inotropes, and Antiarrythmic Agents 22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics 23. Sleep and Sleep Pharmacology Appendix A: Answers to Self-Assessment Questions and Clinical Scenarios Appendix B: Units and Systems of Measurement Appendix C: Acceptable Mixtures of Most Commonly Prescribed Respiratory Care Drugs Glossary of Selected Terms Drug Index Abbreviations
£86.44
Elsevier Health Sciences Study Guide for Pharmacology
Book Synopsis
£35.02
Elsevier - Health Sciences Division Brenner and Stevens Pharmacology
Book SynopsisTable of ContentsSection I: Principles of Pharmacology Chapter 1 Introduction to Pharmacology Chapter 2 Pharmacokinetics Chapter 3 Pharmacodynamics Chapter 4 Drug Development and Safety Chapter 5 Toxicology and the Treatment of Poisoning Section II: Autonomic and Neuromuscular Pharmacology Chapter 6 Peripheral Neuropharmacology and Acetylcholine Agonists Chapter 7 Acetylcholine Receptor Antagonists Chapter 8 Sympathetic Neurotransmission and Adrenoceptor Agonists Chapter 9 Adrenoceptor Antagonists Section III: Cardiovascular, Renal, and Hematologic Pharmacology Chapter 10 Antihypertensive Drugs Chapter 11 Antianginal Drugs Chapter 12 Drugs for Heart Failure Chapter 13 Diuretics Chapter 14 Drugs for Cardiac Dysrhythmia Chapter 15 Drugs for Hyperlipidemia Chapter 16 Antithrombotic and Thrombolytic Drugs Chapter 17 Hematopoietic Drugs Section IV: Central Nervous System Pharmacology Chapter 18 Introduction to Central Nervous System Pharmacology Chapter 19 Sedative-Hypnotic and Anxiolytic Drugs Chapter 20 Antiepileptic Drugs Chapter 21 Local and General Anesthetics Chapter 22 Psychotherapeutic Drugs Chapter 23 Opioid Analgesics and Antagonists Chapter 24 Drugs for Neurodegenerative Diseases Chapter 25 Drugs of Abuse Section V: Pharmacology of Respiratory and Other Systems Chapter 26 Autacoid Drugs Chapter 27 Respiratory Pharmacology Chapter 28 Gastrointestinal Pharmacology Chapter 29 Drugs for Headache Disorders Chapter 30 Drugs for Pain, Inflammation, and Arthritic Disorders Section VI: Endocrine Pharmacology Chapter 31 Hypothalamic and Pituitary Drugs Chapter 32 Thyroid Drugs Chapter 33 Adrenal Steroids and Related Drugs Chapter 34 Drugs Affecting Fertility and Reproduction Chapter 35 Drugs for Diabetes Chapter 36 Drugs Affecting Calcium and Bone Section VII: Chemotherapy Chapter 37 Principles of Antimicrobial Chemotherapy Chapter 38 Inhibitors of Bacterial Cell Wall Synthesis Chapter 39 Inhibitors of Bacterial Protein Synthesis Chapter 40 Quinolones, Antifolate Drugs, and Other Antimicrobial Agents Chapter 41 Antimycobacterial Drugs Chapter 42 Antifungal Drugs Chapter 43 Antiviral Drugs Chapter 44 Antiparasitic Drugs Chapter 45 Antineoplastic Drugs Chapter 46 Immunotherapeutic Agents
£51.29
Elsevier - Health Sciences Division Ciottones Disaster Medicine
Book SynopsisTable of ContentsPart 1: Overview of Disaster Management Section 1: Introduction Section 2: Domestic and International Resources Section 3: Pre-Event Topics Section 4: Event-Response Topics Section 5: Mechanical Operations in Disasters Section 6: Post-Event Topics Section 7: Topics Unique to Terrorist Events and High-Threat Disaster Response Section 8: Operational Medicine Part 2: Management of Specific Event Types Section 9: Natural Disasters Section 10: Nuclear/Radiation Events Section 11: Chemical Events Section 12: Biological Events: Introduction Section 12: Biological Events, Part 1: Bacterial Agents Section 12: Biological Events, Part 2: Viral Agents Section 12: Biological Agents, Part 3, Toxins Section 12: Biological Agents, Part 4: Other Biological Agents Section 13: Events Resulting in Blast Injuries Section 14: Events Resulting in Burn Injuries Section 15: Events Resulting in Ballistic Injuries Section 16: Events Resulting in Structural Collapse/Crashing/Crushing Section 17: Other Events/Combination Events
£116.09
Elsevier - Health Sciences Division Essentials of Pharmacology and Therapeutics for
Book SynopsisTable of Contents1) Pharmacodynamics 2) Pharmacokinetics and Pharmacogenetics 3) Pharmacotherapeutics 4) Introduction to autonomic nervous system (ANS) 5) Autonomic Drugs (adrenergic and cholinergic) 6) General anesthetics and sedative-hypnotic drugs 7) Local Anesthetics 8) Anti-infective agents (antibiotics, antifungal, antiviral) 9) Analgesics and Acute Pain Management 10) Autacoids 11) Anticonvulsants and antiparkinsonian drugs 12) Bone sparing drugs 13) Cardiac and vascular drugs 14) Drugs action on respiratory system 15) Endocrine drugs (Parathyroid, Adrenals, Insulin, Sex Steroids) 16) Immunological drugs 17) Antineoplastics 18) Toxicology and adverse drug interactions 19) Drugs specific to dentistry 20) Emergency drugs 21) Prescription Writing
£37.04
Elsevier Clinical Calculations Binder Ready
Book Synopsis
£77.89
Elsevier Health Sciences Brodys Human Pharmacology
Book Synopsis
£53.09